粤万年青(301111) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥71,196,522.47, a decrease of 10.22% compared to ¥79,304,090.52 in the same period last year[5] - The net profit attributable to shareholders for Q1 2024 was ¥11,738,167.74, down 20.78% from ¥14,816,687.61 in the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥8,233,020.31, a decline of 28.16% from ¥10,825,582.19 in Q1 2023[5] - Total operating revenue for Q1 2024 was CNY 71,196,522.47, a decrease of 10.6% compared to CNY 79,304,090.52 in Q1 2023[20] - Net profit for Q1 2024 was CNY 11,469,685.34, down 22.5% from CNY 14,816,637.93 in Q1 2023[21] - Operating profit for Q1 2024 was CNY 13,315,867.35, a decline of 23.5% compared to CNY 17,439,893.78 in Q1 2023[21] - The total comprehensive income for the parent company in Q1 2024 is CNY 11,738,167.74, compared to CNY 14,816,687.61 in Q1 2023, reflecting a decline of 20.0%[22] Cash Flow and Assets - The company's cash flow from operating activities showed a significant improvement, with a net outflow of only ¥68,441.98 compared to a net outflow of ¥20,027,562.27 in the same period last year, representing a 99.66% change[11] - Cash inflows from operating activities totaled CNY 69,880,833.89, down 9.9% from CNY 77,481,648.86 in the previous year[25] - The net cash flow from operating activities for Q1 2024 is CNY -68,441.98, compared to CNY -20,027,562.27 in Q1 2023, indicating a significant improvement in cash flow management[25] - The company reported a decrease in cash and cash equivalents, with a balance of ¥122,947,397.98 at the end of the period compared to ¥131,109,311.54 at the beginning[16] - Cash and cash equivalents at the end of Q1 2024 amount to CNY 90,113,313.39, down from CNY 120,491,579.09 at the end of Q1 2023[26] - The company's total assets at the end of Q1 2024 were ¥867,102,691.52, reflecting a 1.35% increase from ¥855,535,468.09 at the end of the previous year[5] - The company's total assets as of Q1 2024 amounted to CNY 867,102,691.52, up from CNY 855,535,468.09 at the end of Q1 2023[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,326[12] - Guangdong Jinou Health Technology Co., Ltd. holds 45.00% of shares, totaling 72,000,000 shares[12] - The top ten shareholders collectively hold significant stakes, with 合和投资控股 (Guangzhou) Partnership holding 11.25% (18,000,000 shares) and 广东侨银房地产开发有限公司 holding 7.50% (12,000,000 shares)[12] - The top ten unrestricted shareholders include 合和投资控股 (Guangzhou) Partnership with 18,000,000 shares and 广东中小企业股权投资基金有限公司 with 3,841,700 shares[12] - The total number of shares held by the top ten shareholders represents a significant portion of the company's equity, indicating concentrated ownership[12] Expenses and Liabilities - Management expenses increased by 67.95% to ¥7,864,013.43 due to new lease agreements and increased staffing costs[10] - Total liabilities decreased to CNY 75,927,828.65 in Q1 2024 from CNY 77,330,290.56 in Q1 2023[18] - Research and development expenses for Q1 2024 were CNY 2,261,389.75, compared to CNY 2,165,209.75 in Q1 2023, indicating a slight increase[21] Investments and Financing - The company reported a significant increase in accounts receivable financing, which rose by 91.92% to ¥14,780,474.71 from ¥7,701,250.75[10] - The company has made new investments in equity instruments totaling ¥5,550,000.00, indicating a strategic move towards expanding its investment portfolio[10] - The company reported a financial asset investment of CNY 240,049,916.67, slightly up from CNY 238,078,250.00 in Q1 2023[17] Other Information - The company has not reported any changes in the number of shares lent or returned through margin trading[14] - The company has not disclosed any new product developments or market expansion strategies in the current report[15] - There are no indications of mergers or acquisitions in the recent financial disclosures[15] - The company has not undergone an audit for the Q1 2024 report[27] - The company is set to implement new accounting standards starting in 2024, which may impact future financial reporting[27]